Track the Gland Pharma share price and the full insider trade history of the company, a publicly traded company based in India. Shares trade on IN IN, under the authority of SEBI (PIT + SAST). Market capitalisation: €413.1bn. The latest transaction was filed on 3 August 2026 (Disposal). Among the most active insiders: Jayatheerth Advani. The full history is openly available.
8
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€109,578
8 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Gland Pharma Buy (bullish), based on 14 analysts. Average price target: ₹2,325.29.
10Σ signal
Buys n/a€109,578 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 10,192 of 27,969 companies
58.4
score / 100
Value
37
Quality
79
FCF yld1.2%
Earn yld2.4%
EV/EBITDA22.5x
ROE11%
Gross mgn65%
Net mgn16%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.